Product image of Letybo (Botulinum Toxin Type A) supplied by GNH India

Letybo

Active Ingredient:
Botulinum Toxin Type A
Origin:
EU

Letybo (Botulinum Toxin Type A)

Botulinum toxin type A, the active ingredient in Letybo, is a neuromuscular blocking agent presented as a sterile injectable for intramuscular use. It provides temporary muscle relaxation in conditions characterized by excessive muscle activity. It is indicated for several neuromuscular disorders and is administered by trained healthcare professionals under aseptic conditions.

GNH India supplies Letybo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance, and reliable cold‑chain logistics for this injectable biologic.

Manufacturer / TM Owner

Croma Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Letybo, a botulinum toxin type A preparation, is used to manage disorders involving abnormal muscle contraction or excessive glandular activity.

  • Cervical dystonia: reduces abnormal neck muscle tone and improves head positioning.
  • Blepharospasm: alleviates involuntary eyelid closure and associated discomfort.
  • Chronic migraine: decreases frequency of migraine attacks when administered prophylactically.
  • Upper limb spasticity: relaxes overactive muscles to improve functional movement.
  • Axillary hyperhidrosis: diminishes excessive sweating in the underarm region.

How It Works

  • Botulinum toxin type A cleaves the synaptic protein SNAP‑25 within presynaptic nerve terminals, preventing the release of acetylcholine at the neuromuscular junction. By blocking this neurotransmitter, the drug induces a reversible inhibition of muscle contraction, leading to temporary paralysis of the targeted muscle fibers. The effect persists until new nerve terminals are formed, typically lasting several weeks to months and functional improvement.

Side Effects

Adverse reactions to Letybo are generally related to the injection site and the pharmacologic action of botulinum toxin.

Common Side Effects

  • Injection site pain: mild to moderate discomfort at the administration site.
  • Bruising: localized discoloration due to minor bleeding.
  • Headache: transient headache occurring after treatment.
  • Neck pain: soreness in the neck muscles.
  • Flu‑like symptoms: temporary fatigue, low‑grade fever or malaise.

Serious or Rare Side Effects

  • Dysphagia: difficulty swallowing that may require medical attention.
  • Respiratory compromise: breathing difficulties due to spread of toxin.
  • Anaphylaxis: severe allergic reaction with hives, swelling or shock.
  • Botulism‑like systemic spread: generalized muscle weakness beyond the injection area.
  • Urinary retention: difficulty emptying the bladder.

Precautions & Warnings

Before using Letybo, consider the following precautions to ensure safe and effective treatment.

  • Pregnancy: safety not established; avoid unless potential benefit justifies the risk.
  • Breastfeeding: unknown effects; weigh maternal benefit against possible infant exposure.
  • Neuromuscular disorders: use with caution in patients with myasthenia gravis or Lambert‑Eaton syndrome.
  • Concomitant aminoglycosides or muscle relaxants: monitor for enhanced neuromuscular blockade.
  • Allergy: assess for hypersensitivity to botulinum toxin or any formulation components.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Letybo may interact with other medications that affect neuromuscular transmission or toxin metabolism.

Major Interactions (Avoid)

  • Aminoglycoside antibiotics: can potentiate neuromuscular blockade leading to severe weakness.
  • Other botulinum toxin products: cumulative effect may increase risk of systemic toxicity.
  • Neuromuscular blocking agents used in anesthesia: may cause prolonged paralysis.

Moderate Interactions (Monitor Closely)

  • Anticholinergic drugs: may modify clinical response to toxin.
  • Calcium channel blockers: possible enhancement of muscle weakness.
  • General anesthetics (inhalational agents): may influence recovery from neuromuscular blockade.

Frequently Asked Questions

Letybo is indicated for several neuromuscular and glandular disorders, including cervical dystonia, blepharospasm, chronic migraine prophylaxis, upper‑limb spasticity, and severe axillary hyperhidrosis. In each case the product is injected into the affected muscles or glands to produce temporary relaxation or reduced activity.

Botulinum toxin type A blocks the release of acetylcholine at the neuromuscular junction by cleaving the SNAP‑25 protein inside presynaptic nerve endings. This interruption prevents muscle contraction, resulting in a reversible, localized paralysis that lasts until new nerve terminals are regenerated.

The appropriate dose of Letybo is set by the prescribing clinician based on the specific indication, the size and number of muscles being treated, patient weight, and prior response to therapy. No fixed regimen is provided; the healthcare professional tailors the amount to each individual case.

Safety data for Letybo in pregnancy and lactation are limited. The product is classified as having an unknown pregnancy category, and its excretion in breast milk has not been established. Use is generally avoided unless the potential therapeutic benefit outweighs the possible risk to the fetus or infant.

To request Letybo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

Letybo contains botulinum toxin type A, the same active molecule found in other branded products such as Botox® or Dysport®. Differences lie mainly in formulation, unit potency, and approved indications. Clinical efficacy and safety are comparable when administered by experienced clinicians, but dosing units are not interchangeable across brands.

Letybo should be stored in a refrigerator at 2 °C to 8 °C. Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking the product. Maintaining the cold‑chain is essential to preserve potency and safety.

Letybo is supplied as a sterile liquid for intramuscular injection. A qualified healthcare professional reconstitutes the vial (if required), selects the appropriate injection sites, and delivers the calculated dose using a fine‑gauge needle under aseptic technique. The procedure is performed in a clinical setting.

Serious adverse events include dysphagia, respiratory compromise, generalized muscle weakness resembling botulism, anaphylaxis, and urinary retention. These reactions may indicate spread of toxin beyond the intended area and require immediate medical evaluation. Patients should be monitored closely after injection, especially when treating large muscle groups.

Letybo is contraindicated in individuals with a known hypersensitivity to botulinum toxin type A or any excipients in the formulation. It should also be avoided in patients with active infections at the injection site, those with certain neuromuscular disorders such as myasthenia gravis, or anyone taking medications that markedly increase neuromuscular blockade without careful monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Botulinum Toxin Type A

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT